Bone mineral density and associated factors in postmenopausal women with type 2 diabetes
Main Article Content
Abstract
Osteoporosis is a common complication in postmenopausal women with type 2 diabetes mellitus (T2DM). However, domestic data on bone mineral density (BMD) and related factors in this population remain limited. A study of 111 postmenopausal women with T2DM at Nguyen Tri Phuong Hospital from January 2024 to October 2024 showed a median menopausal age of 50 years old and an average menopausal duration of 17.6 years. The mean BMI was 23.7 ± 3.2 kg/m², with 29.7% classified as obese and 64% having central obesity. The median BMD at the lumbar spine and femoral neck was 0.814 g/cm² and 0.599 g/cm², respectively. The prevalence of osteoporosis was 39.6% at the lumbar spine, 45% at the femoral neck, and 61.3% at least at one site. Multivariate analysis did not identify age as significantly associated with reduced femoral neck BMD (p = 0.030). These findings indicate that osteoporosis is a prevalent complication in postmenopausal women with T2DM, particularly at the femoral neck.
Article Details
Keywords
Bone mineral density, menopause, type 2 diabetes mellitus
References
2. Chen F, Wang P, Dai F, et al. Correlation Between Blood Glucose Fluctuations and Osteoporosis in Type 2 Diabetes Mellitus. Int J Endocrinol. 2025; 2025: 8889420. doi:10.1155/ije/8889420.
3. Stevenson J. Prevention and treatment of osteoporosis in women. Post Reprod Health. Mar 2023; 29(1): 11-14. doi:10.1177/20533691221139902.
4. Greere DII, Grigorescu F, Manda D, Lautier C, Poianã C. Insulin resistance and pathogenesis of postmenopausal osteoporosis. Acta Endocrinol (Buchar). Jul-Sep 2023; 19(3): 349-363. doi:10.4183/aeb.2023.349.
5. Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-Restrepo DF, Carcelén-Fraile MDC, López-Ruiz E. Current Status of the Diagnosis and Management of Osteoporosis. Int J Mol Sci. Aug 21 2022; 23(16). doi:10.3390/ijms23169465.
6. Sundararaghavan V, Mazur MM, Evans B, Liu J, Ebraheim NA. Diabetes and bone health: latest evidence and clinical implications. Ther Adv Musculoskelet Dis. Mar 2017; 9(3): 67-74. doi:10.1177/1759720x16687480.
7. Phan Hữu Hên, Cao Đình Hưng, Trương Quốc Dũng. Tỷ lệ và yếu tố nguy cơ loãng xương ở bệnh nhân nữ mãn kinh mắc đái tháo đường típ 2 tại Bệnh viện Chợ Rẫy năm 2024. Tạp chí Y học Việt Nam. 2025; 546(2 (2025)): 283-287.
8. Trần Bùi Hoài Vọng, Trần Hữu Dàng, Trần Thừa Nguyên. Khảo sát tình trạng loãng xương ở phụ nữ mãn kinh có bệnh đái tháo đường týp 2. Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế. 2014; 20(2014): 10-14.
9. Karimifar M, Pasha MA, Salari A, Zamani A, Salesi M, Motaghi P. Evaluation of bone loss in diabetic postmenopausal women. J Res Med Sci. Nov 2012; 17(11): 1033-8.
10. Wongdee K, Charoenphandhu N. Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms. World J Diabetes. Mar 15 2011; 2(3): 41-8. doi:10.4239/wjd.v2.i3.41.
11. Dytfeld J, Michalak M. Type 2 diabetes and risk of low-energy fractures in postmenopausal women: meta-analysis of observational studies. Aging Clin Exp Res. Apr 2017; 29(2): 301-309. doi:10.1007/s40520-016-0562-1.
12. Trương Quốc Dũng. Tỷ lệ và yếu tố nguy cơ loãng xương ở bệnh nhân nữ mãn kinh mắc đái tháo đường típ 2. Luận văn Thạc sĩ Y học. Đại học Y khoa Phạm Ngọc Thạch; 2024.
13. Föger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K, Pietschmann P. Osteoporosis: Pathophysiology and therapeutic options. Excli j. 2020; 19: 1017-1037. doi:10.17179/excli2020-2591.
14. Luo W, Li X, Zhou Y, Xu D, Qiao Y. Correlation between bone mineral density and type 2 diabetes mellitus in elderly men and postmenopausal women. Sci Rep. Jul 2 2024; 14(1): 15078. doi:10.1038/s41598-024-65571-7.